Daniel K Spiegelman - Net Worth and Insider Trading
Daniel K Spiegelman Net Worth
The estimated net worth of Daniel K Spiegelman is at least $5 Million dollars as of 2024-07-16. Daniel K Spiegelman is the EVP, CFO of Biomarin Pharmaceutical Inc and owns about 47,510 shares of Biomarin Pharmaceutical Inc (BMRN) stock worth over $4 Million. Daniel K Spiegelman is the Director of Myriad Genetics Inc and owns about 32,917 shares of Myriad Genetics Inc (MYGN) stock worth over $901,597. Daniel K Spiegelman is also the Director of Relypsa Inc and owns about 1,237 shares of Relypsa Inc (RLYP) stock worth over $39,572. Details can be seen in Daniel K Spiegelman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Daniel K Spiegelman has not made any transactions after 2024-06-04 and currently still holds the listed stock(s).
Transaction Summary of Daniel K Spiegelman
Daniel K Spiegelman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel K Spiegelman owns 10 companies in total, including Spruce Biosciences Inc (SPRB) , Myriad Genetics Inc (MYGN) , and Biomarin Pharmaceutical Inc (BMRN) among others .
Click here to see the complete history of Daniel K Spiegelman’s form 4 insider trades.
Insider Ownership Summary of Daniel K Spiegelman
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SPRB | Spruce Biosciences Inc | 2020-10-08 | director |
MYGN | Myriad Genetics Inc | 2024-06-04 | director |
BMRN | Biomarin Pharmaceutical Inc | 2019-04-01 | EVP & Chief Financial Officer |
2018-03-09 | director | ||
2016-09-01 | director | ||
2014-06-13 | director | ||
2012-06-13 | director | ||
2009-12-08 | director | ||
2006-06-14 | director | ||
2020-11-18 | director |
Daniel K Spiegelman Latest Holdings Summary
Daniel K Spiegelman currently owns a total of 3 stocks. Among these stocks, Daniel K Spiegelman owns 47,510 shares of Biomarin Pharmaceutical Inc (BMRN) as of April 1, 2019, with a value of $4 Million and a weighting of 81.26%. Daniel K Spiegelman owns 32,917 shares of Myriad Genetics Inc (MYGN) as of June 4, 2024, with a value of $901,597 and a weighting of 17.95%. Daniel K Spiegelman also owns 1,237 shares of Relypsa Inc (RLYP) as of June 7, 2016, with a value of $39,572 and a weighting of 0.79%.
Latest Holdings of Daniel K Spiegelman
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
BMRN | Biomarin Pharmaceutical Inc | 2019-04-01 | 47,510 | 85.89 | 4,080,634 |
MYGN | Myriad Genetics Inc | 2024-06-04 | 32,917 | 27.39 | 901,597 |
RLYP | Relypsa Inc | 2016-06-07 | 1,237 | 31.99 | 39,572 |
Holding Weightings of Daniel K Spiegelman
Daniel K Spiegelman Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel K Spiegelman has made a total of 0 transactions in Biomarin Pharmaceutical Inc (BMRN) over the past 5 years. The most-recent trade in Biomarin Pharmaceutical Inc is the sale of 13,473 shares on April 1, 2019, which brought Daniel K Spiegelman around $1 Million.
According to the SEC Form 4 filings, Daniel K Spiegelman has made a total of 4 transactions in Myriad Genetics Inc (MYGN) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Myriad Genetics Inc is the sale of 7,576 shares on June 4, 2024, which brought Daniel K Spiegelman around $167,051.
According to the SEC Form 4 filings, Daniel K Spiegelman has made a total of 0 transactions in Relypsa Inc (RLYP) over the past 5 years. The most-recent trade in Relypsa Inc is the sale of 1,013 shares on June 7, 2016, which brought Daniel K Spiegelman around $19,561.
Insider Trading History of Daniel K Spiegelman
- 1
Daniel K Spiegelman Trading Performance
Daniel K Spiegelman Ownership Network
Ownership Network List of Daniel K Spiegelman
Ownership Network Relation of Daniel K Spiegelman
Daniel K Spiegelman Owned Company Details
What does Spruce Biosciences Inc do?
Who are the key executives at Spruce Biosciences Inc?
Daniel K Spiegelman is the director of Spruce Biosciences Inc. Other key executives at Spruce Biosciences Inc include 10 percent owner Novo Holdings A/s , Chief Medical Officer Charlton Ralph William Iii , and director & Chief Executive Officer Javier B. Szwarcberg .
Spruce Biosciences Inc (SPRB) Insider Trades Summary
Over the past 18 months, Daniel K Spiegelman made no insider transaction in Spruce Biosciences Inc (SPRB). Other recent insider transactions involving Spruce Biosciences Inc (SPRB) include a net sale of 1,964,336 shares made by Novo Holdings A/s , and a net purchase of 630,400 shares made by Niall O'donnell .
In summary, during the past 3 months, insiders sold 0 shares of Spruce Biosciences Inc (SPRB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,172,336 shares of Spruce Biosciences Inc (SPRB) were sold and 2,838,400 shares were bought by its insiders, resulting in a net sale of 1,333,936 shares.
Spruce Biosciences Inc (SPRB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Spruce Biosciences Inc Insider Transactions
Daniel K Spiegelman Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel K Spiegelman. You might contact Daniel K Spiegelman via mailing address: Myriad Genetics, 320 Wakara Way, Salt Lake City Ut 84003.